
Sign up to save your podcasts
Or


When we think about medicine’s war on cancer, treatments such as surgery, radiation and chemotherapy spring to mind first. Now there is another potential weapon for defeating tumors: statistics and mathematical models that can optimize the selection, combination or timing of treatment. Building and feeding these models requires accounting for the complexity of the body, and recognizing that cancer cells are constantly evolving.
In this episode, host Steven Strogatz hears from Franziska Michor, a computational biologist, about how our understanding of evolutionary dynamics is being used to devise new anticancer therapies.
By Steven Strogatz, Janna Levin and Quanta Magazine4.9
495495 ratings
When we think about medicine’s war on cancer, treatments such as surgery, radiation and chemotherapy spring to mind first. Now there is another potential weapon for defeating tumors: statistics and mathematical models that can optimize the selection, combination or timing of treatment. Building and feeding these models requires accounting for the complexity of the body, and recognizing that cancer cells are constantly evolving.
In this episode, host Steven Strogatz hears from Franziska Michor, a computational biologist, about how our understanding of evolutionary dynamics is being used to devise new anticancer therapies.

753 Listeners

946 Listeners

323 Listeners

835 Listeners

565 Listeners

543 Listeners

233 Listeners

819 Listeners

1,059 Listeners

4,169 Listeners

2,366 Listeners

505 Listeners

252 Listeners

324 Listeners

17 Listeners

383 Listeners